These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2982268)

  • 1. Collagen sponge as vaginal contraceptive barrier: critical summary of seven years of research.
    Chvapil M; Droegemueller W; Heine MW; MacGregor JC; Dotters D
    Am J Obstet Gynecol; 1985 Feb; 151(3):325-9. PubMed ID: 2982268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lea's Shield: a study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide.
    Mauck C; Glover LH; Miller E; Allen S; Archer DF; Blumenthal P; Rosenzweig A; Dominik R; Sturgen K; Cooper J; Fingerhut F; Peacock L; Gabelnick HL
    Contraception; 1996 Jun; 53(6):329-35. PubMed ID: 8773419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravaginal contraceptive sponge impregnated with nonoxynol-9. The development of sponge for clinical efficacy trials.
    Takano R
    Nihon Funin Gakkai Zasshi; 1980 Oct; 25(4):80-7. PubMed ID: 12158575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal contraception--an update.
    Edelman DA; Thompson S
    Contracept Deliv Syst; 1982 Apr; 3(2):75-81. PubMed ID: 12338173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyurethane contraceptive vaginal sponge: product modifications resulting from user experience.
    Aznar R; Zamora G; Lozano M; Levi C
    Contraception; 1981 Sep; 24(3):235-44. PubMed ID: 7030612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative trial of the Today contraceptive sponge and diaphragm.
    Edelman DA; McIntyre SL; Harper J
    Am J Obstet Gynecol; 1984 Dec; 150(7):869-76. PubMed ID: 6095664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the intravaginal insert (IVI): acceptability, side effects, and post-coital spermicidal activity.
    Ahmad M; Asch RH
    Acta Eur Fertil; 1984; 15(5):369-76. PubMed ID: 6099026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonprescription vaginal contraception.
    Edelman DA
    Int J Gynaecol Obstet; 1980; 18(5):340-4. PubMed ID: 6110578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate.
    Psychoyos A; Creatsas G; Hassan E; Georgoulias V; Gravanis A
    Hum Reprod; 1993 Jun; 8(6):866-9. PubMed ID: 7688380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on vaginal malodor. I. Study in humans.
    Chvapil M; Eskelson C; Jacobs S; Chvapil T; Russell DH
    Obstet Gynecol; 1978 Jul; 52(1):88-93. PubMed ID: 28501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary testing of the contraceptive collagen sponge.
    Chvapil M; Droegemueller W; Betts K; Heine W; Weinstein L
    Obstet Gynecol; 1980 Oct; 56(4):503-6. PubMed ID: 7191547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vaginal contraceptive sponge.
    Edelman DA
    IPPF Med Bull; 1984 Jun; 18(3):1-2. PubMed ID: 12266284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal mechanical contraceptive devices.
    Smith M; Barwin BN
    Can Med Assoc J; 1983 Oct; 129(7):699-701, 710. PubMed ID: 6616379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lea's Shield: a phase I postcoital study of a new contraceptive barrier device.
    Archer DF; Mauck CK; Viniegra-Sibal A; Anderson FD
    Contraception; 1995 Sep; 52(3):167-73. PubMed ID: 7587188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sponge subject of research, controversy in second year.
    Contracept Technol Update; 1985 Jul; 6(7):93-6. PubMed ID: 12280148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of barrier methods of contraception with and without spermicide.
    Craig S; Hepburn S
    Contraception; 1982 Oct; 26(4):347-59. PubMed ID: 6759027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-STD vaginal contraceptive sponges.
    Hassan E; Creatsas G; Gravanis A; Georgoulias V; Psychoyos A
    Ann N Y Acad Sci; 1997 Jun; 816():451-6. PubMed ID: 9238301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the amount of nonoxynol-9 remaining in the vagina up to 4 h after insertion of a vaginal contraceptive film (VCF) containing 70 mg nonoxynol-9.
    Mauck CK; Allen S; Baker JM; Barr SP; Abercrombie T; Archer DF
    Contraception; 1997 Aug; 56(2):103-10. PubMed ID: 9315419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lea's Shield, a new barrier contraceptive preliminary clinical evaluations three-day tolerance study.
    Hunt WL; Gabbay L; Potts M
    Contraception; 1994 Dec; 50(6):551-61. PubMed ID: 7705097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical acceptability, use-patterns and use-effectiveness of the vaginal contraceptive sponge and Neo Sampoon tablets--an international multi-center randomized clinical trial.
    Chi IC; Smith SC; Borko E; Sun TH; Begum SF; Hunt WL; Wilkens LR
    Contraception; 1987 Nov; 36(5):499-514. PubMed ID: 3329078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.